Introduction
Pyrazinoate, a metabolite of the antituberculous drug pyrazinamide, suppresses the renal excretion of urate (1, 2) . This effect has been attributed to inhibition of the secretory component of bidirectional urate transport in the proximal tubule and forms the basis for the pyrazinamide suppression test in man (3) . When given in higher doses, pyrazinoate actually enhances urate excretion (2, 4) . Several other substances, such as salicylate, also have the paradoxical property of inhibiting urate excretion when administered in low doses and of stimulating urate excretion when given in high doses (5) .
Previous work has identified a probenecid-sensitive anion exchanger that can account for uphill urate reabsorption across the luminal (microvillus, brush border) membrane of the proximal tubular cell of dog and rat (6) (7) (8) (9) . This transport system mediates the exchange of urate for any of several anions for which a cell-to-lumen electrochemical gradient is present across the luminal membrane. The known substrates for exchange with urate via this pathway are OH-, Cl-, paminohippurate (PAH),' several monocarboxylic acid anions (i.e., valerate, lactate, beta-hydroxybutyrate, pyruvate, and acetoacetate), the monovalent forms of certain dicarboxylic acid anions (i.e., maleate, succinate, alpha-ketoglutarate, and oxaloacetate), and the tricarboxylic acid anion cis-aconitate (6) (7) (8) .
We now report that pyrazinoate and nicotinate, another substance that causes urate retention (10) , are substrates for the dog renal microvillus membrane anion exchange pathway shared by urate. Moreover, pyrazinoate and nicotinate are also substrates for an organic anion-Na+ cotransport pathway not shared by urate. We demonstrate an interaction between these two luminal membrane transport systems in vitro that can explain the paradoxical effects of pyrazinoate and other compounds on urate excretion in vivo.
Methods
Membrane preparation. Microvillus membrane vesicles were isolated from mongrel dog renal cortex by the Mg++ aggregation method previously described (6) . In general, the membranes were prepared and suspended (25-30 mg membrane protein/ml) in a medium of 200 mM mannitol, 10 mM MgSO4, and 80 mM Hepes titrated to pH 7.5 with 41 mM KOH (8) . Membrane vesicles were frozen and stored at -700C until used (7, 8) .
Solute uptake studies. Uptake of radiolabeled solutes was assayed at 20°C by the rapid filtration technique previously described (11) , using a stopping and washing solution of 170 mM Na gluconate, 2 mM K probenecid, 2.5 mM Tris, and 4 mM Hepes, pH 7.5 (8) (7) , and urate uptake is markedly affected by variations in the transmembrane pH gradient (6, 8) . Accordingly, the effect of the pyrazinoate gradient was evaluated by using vesicles with equal internal and external K+ concentrations in the presence of the K+ ionophore valinomycin (3 mg/ml) to shortcircuit anion diffusion potentials (voltage clamp) and in the presence of the K+-H' exchanger nigericin (150 tg/ml) to collapse pH gradients (pH clamp). In other experiments, the effects of outward OH-gradients on organic anion uptake were evaluated. These experiments were performed in the presence of the K+-valinomycin voltage clamp to short-circuit H'/OH-diffusion potentials. The efficacy of the valinomycin voltage clamp and the nigericin pH clamp in these membranes has been demonstrated previously (8 
Results
Our initial method to test the hypothesis that pyrazinoate shares the urate exchange pathway was to determine whether pyrazinoate would exchange with urate. As shown in Fig. 1 ['4Cjpyrazinoate in the presence (pHo 6.5; pH; 7.5) or absence (pH-7.5; pH1 7.5) of an outward OH-gradient (Fig. 2) . This experiment was conducted in the presence of a valinomycin voltage clamp. As indicated in Fig. 2 In rabbit renal microvillus membrane vesicles, Na'-nicotinate cotransport takes place and is inhibited by pyrazinoate but not by PAH (12) . We therefore tested for the presence of Na+-pyrazinoate cotransport in dog microvillus membranes, as shown in Fig. 4 Na+-lactate cotransport has been documented in microvillus membrane vesicles from rat (13) , dog (8) , and rabbit (14) , and occurs via a pathway shared by many other monocarboxylic acid anions (14) . This Na+-cotransport system is not shared by urate, inasmuch as Na+-lactate cotransport is not inhibited by urate (8) , and the initial rate of urate uptake is not stimulated by Na+ (7) . If Na+-pyrazinoate cotransport takes place via the same pathway that mediates Na+-lactate cotransport, then Na+-stimulated pyrazinoate uptake should be sensitive to inhibition by the same substances that inhibit Na+-stimulated lactate uptake. This prediction was tested in the experiments illustrated in Fig. 5 cotransport system in dog renal microvillus membranes.
We then attempted to demonstrate paradoxical effects of pyrazinoate and nicotinate on urate uptake in our membrane vesicle preparation. In Fig. 1, we showed that an outward pyrazinoate gradient could stimulate urate accumulation. In Fig. 4 , we showed that an inward Na' gradient could induce the uphill accumulation of pyrazinoate. That is, an inward Na+ gradient at least transiently could generate an outward pyrazinoate gradient. It therefore seemed possible that adding pyrazinoate to the external medium in the presence of an inward Na+ gradient might stimulate urate accumulation. On the other hand, adding higher concentrations of pyrazinoate might reduce urate uptake as cis inhibition at the external face of the membrane became the predominant effect, as observed in Fig. 3 . In the experiment illustrated in Fig. 6 , the uptake of 48 MM ['4C]urate was assayed in the presence of an inward Na' gradient with 0, 0.1, or 5 mM pyrazinoate added to the external medium at the initiation of the uptake measurement. The lower dose of pyrazinoate stimulated the accumulation of urate and induced a transient overshoot. In contrast, the higher dose of pyrazinoate inhibited the rate of urate uptake.
Similar effects were noted with nicotinate (Fig. 7) (15) , two species in which there is active, mediated urate reabsorption in the proximal tubule (16, 17) and in which urate transport via anion exchange has been demonstrated in renal microvillus membrane vesicles (6) (7) (8) (9) . In contrast, pyrazinoate does not reduce urate excretion in the rabbit (18) . Rabbit proximal tubules secrete urate actively but have no mediated urate reabsorption (19, 20 
